Literature DB >> 6325539

An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.

M Vaara, P Viljanen, T Vaara, P H Mäkelä.   

Abstract

The small cationic outer membrane-disorganizing peptide PMBN sensitized four smooth, encapsulated strains of Escherichia coli (serotypes 02:K1, 04:K12, 018:K1, and 018:K5) to the lethal action of serum. The concentrations of PMBN required were low (0.3 to 1.0 microgram/ml). One E. coli strain (IH 11030; 075:K5) remained virtually resistant to serum and also to anti-075 hyperimmune serum plus complement (C) even in the presence of PMBN. This strain was nevertheless sensitive to the outer membrane permeability-increasing action of PMBN. In the bactericidal system, PMBN could be replaced by high concentrations of lysine20 or protamine but not lysine4. The PMBN-dependent bactericidal activity of GPS was abolished by heating or zymosan treatment that inactivate its C but not by lack of the action of the classical pathway of the C in C4-deficient GPS. PMBN formed a bactericidal system also with normal rabbit, rat, and human serum but not with mouse serum. The bactericidal system against E. coli 018:K1 and its derivative EH 817 (018:K1-) was found to require a factor that can be removed from normal sera by absorption with a rough E. coli strain. This factor could be replaced by specific anti-018 antibodies. The bactericidal activity of fetal calf serum plus PMBN against E. coli 018:K1 was enhanced by normal rabbit or anti-E. coli 018 hyperimmune serum. We suggest that PMBN unshields the deep structures and the hydrophobic membrane milieu of the outer membrane and facilitates the insertion of the membrane attack complex of the C into this milieu.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325539

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

2.  Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide.

Authors:  H S Warren; S A Kania; G R Siber
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

3.  A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.

Authors:  Martti Vaara; Osmo Siikanen; Juha Apajalahti; John Fox; Niels Frimodt-Møller; Hui He; Anima Poudyal; Jian Li; Roger L Nation; Timo Vaara
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

Review 4.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

5.  Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59).

Authors:  R Rautemaa; G A Jarvis; P Marnila; S Meri
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.

Authors:  Michael R Yeaman; Kimberly D Gank; Arnold S Bayer; Eric P Brass
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying poly-C9 deposition.

Authors:  J E Schweinle; M Nishiyasu
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

8.  Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide.

Authors:  R L Danner; K A Joiner; M Rubin; W H Patterson; N Johnson; K M Ayers; J E Parrillo
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.

Authors:  J Weiss; P Elsbach; C Shu; J Castillo; L Grinna; A Horwitz; G Theofan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo.

Authors:  R P Darveau; M D Cunningham; C L Seachord; L Cassiano-Clough; W L Cosand; J Blake; C S Watkins
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.